ReviewFrontiers in oncology2023

Recent advances on anti-angiogenic multi-receptor tyrosine kinase inhibitors in osteosarcoma and Ewing sarcoma.

Emmy D G Fleuren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.